โก Quick Summary
This scoping review examined the effectiveness of technology-enhanced exercise training for managing metabolic syndrome (MetS), highlighting the potential of various digital tools to improve adherence and outcomes. The findings suggest that while promising, the evidence remains preliminary and heterogeneous.
๐ Key Details
- ๐ Studies Reviewed: 19 eligible studies
- ๐งฉ Technologies Explored: Wearables, telemonitoring, mHealth, AI coaching, VR/exergaming, CGM
- โ๏ธ Methodology: PRISMA-ScR guidelines for systematic review
- ๐ Evidence Strength: Strongest for wearables and telemonitoring
๐ Key Takeaways
- ๐ Technology enhances adherence to exercise regimens for MetS management.
- ๐ก Wearables and mHealth provide structured feedback and support.
- ๐ค AI coaching and CGM show potential but require further validation.
- ๐ Short-term interventions dominate the current evidence base.
- โ๏ธ Limitations include inconsistent reporting and limited follow-up durations.
- ๐ Need for equity in technology access and implementation outcomes.
- ๐ Future research should focus on long-term effects and diverse populations.

๐ Background
Metabolic syndrome (MetS) is a cluster of conditions that significantly increases the risk of type 2 diabetes and cardiovascular diseases. It is characterized by central adiposity, elevated blood pressure, dyslipidaemia, and dysglycaemia. While exercise training is known to improve cardiorespiratory fitness and various components of MetS, real-world effectiveness is often hampered by issues such as poor adherence and lack of personalized supervision.
๐๏ธ Study
This scoping review aimed to map the clinical intervention evidence surrounding technology-enhanced exercise and structured physical activity relevant to MetS. The researchers conducted a comprehensive search across multiple databases, including PubMed, Scopus, and Web of Science, to identify studies that utilized various technological interventions alongside exercise training.
๐ Results
Out of the studies reviewed, the evidence was predominantly focused on wearable devices and telemonitoring approaches. Most studies were either randomized or cluster-randomized, but they typically featured short intervention durations. The technology consistently supported aspects such as adherence, self-monitoring, and remote supervision, with the strongest direct evidence for wearables and telemonitoring.
๐ Impact and Implications
The findings from this review indicate that technology-enhanced exercise training holds promising potential for managing MetS. By leveraging digital tools, healthcare providers can improve patient adherence and outcomes. However, the variability in study designs and the preliminary nature of the evidence suggest that further research is essential to establish standardized protocols and long-term effectiveness.
๐ฎ Conclusion
This scoping review highlights the exciting possibilities of integrating technology into exercise training for MetS management. While the current evidence is still evolving, the potential for improved patient outcomes through enhanced adherence and personalized interventions is clear. Continued exploration in this field is crucial for developing effective strategies to combat MetS and its associated health risks.
๐ฌ Your comments
What are your thoughts on the role of technology in managing metabolic syndrome? We would love to hear your insights! ๐ฌ Join the conversation in the comments below or connect with us on social media:
Technology-Enhanced Exercise Training for Cardiometabolic Syndrome: A Scoping Review.
Abstract
Background: ฮetabolic syndrome (MetS)-comprises central adiposity, elevated blood pressure, dyslipidaemia, and dysglycaemia, increasing the risk of type 2 diabetes and cardiovascular disease. Exercise training improves cardiorespiratory fitness and several MetS components, but real-world effectiveness is limited by poor adherence, restricted supervision, and insufficient personalisation. Objective: This scoping review mapped the clinical intervention evidence on technology-enhanced exercise and structured physical activity relevant to MetS, while distinguishing direct MetS evidence from translational evidence. Methods: In accordance with PRISMA-ScR, we searched PubMed and extended the search to Scopus and Web of Science; a supplementary IEEE Xplore search and a post hoc Embase check were also conducted. Eligible studies were interventions using web-based delivery, wearables, telemonitoring/mobile health (mHealth), artificial intelligence (AI) coaching, virtual reality (VR)/exergaming, or continuous glucose monitoring (CGM) alongside exercise training or structured physical activity. Results: Nineteen studies met the eligibility criteria. The evidence base was weighted toward wearable/app-based feedback and telemonitoring/mHealth/web-based approaches, with fewer studies on VR/exergaming, CGM-enabled exercise, and AI coaching. Most studies were randomised or cluster-randomised, but interventions were usually short term. Across categories, technology most consistently supported adherence, self-monitoring, accountability, remote supervision, and, in selected cases, physiology-informed personalisation. Direct MetS evidence was strongest for wearables with structured feedback, telemonitoring, mHealth, and web-based delivery, whereas AI coaching and CGM were supported by adjacent translational evidence. Conclusions: Technology-enhanced exercise and structured physical activity show promising but heterogeneous and still preliminary potential for MetS management. Key limitations include short follow-up, uneven representation across categories, inconsistent reporting of exercise dose/intensity fidelity and adverse events, and limited equity and implementation outcomes.
Author: [‘Kouidis IA’, ‘Deligiannis P’, ‘Theofanous A’, ‘Anifanti M’, ‘Kouidi E’]
Journal: J Funct Morphol Kinesiol
Citation: Kouidis IA, et al. Technology-Enhanced Exercise Training for Cardiometabolic Syndrome: A Scoping Review. Technology-Enhanced Exercise Training for Cardiometabolic Syndrome: A Scoping Review. 2026; 11:(unknown pages). doi: 10.3390/jfmk11020153